X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

LTRN

Closed

Lantern Pharma Inc

3.15
-0.01 (-0.32%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 3.16
Day's Range: 3.09 - 3.31
Send
When Written:
 
5.12
Lantern Pharma Inc is a clinical stage biopharmaceutical company that uses artificial intelligence and machine learning to develop precision oncology therapies. The company's proprietary AI platform, RADR, analyzes large amounts of genomic and drug data to identify potential drug candidates and predict patient response to treatment. Lantern Pharma focuses on developing therapies for cancer patients with unmet medical needs, including those with drug-resistant tumors. The company's lead drug candidate, LP-184, is in Phase 2 clinical trials for metastatic breast cancer. The company is headquartered in Dallas, Texas, and was founded in 2013.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.58
X